Fang-Yu Li

Fang-Yu Li

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
XSXiaoHan Shen
XiaoHan Shen
YCYung-Yueh Chang
Yung-Yueh Chang
RPRong-Qi Pham
Rong-Qi Pham
WCWei-An Chen
Wei-An Chen
FLFang-Yu Li
Fang-Yu Li
Yu-Wen LinYu-Wen Lin
Yu-Wen Lin
Lung cancer is the leading cause of cancer deaths worldwide, and squamous cell carcinoma (SQC) is Taiwan’s second most common lung carcinoma histotype. This study aimed to investigate changes in the long-term trend of the SQC incidence rate in Taiwan. SQC cases between 1985 and 2019 were adopted from Taiwan‘s Cancer Registry System; the age-adjusted incidence rate was calculated using the World Standard Population in 2000. The long-term trends of the age, period, and birth cohort effect of SQC incidence rates were estimated using the SEER Age-Period-Cohort Web Tool. The results revealed that the incidence of lung carcinoma in Taiwan increased, while the incidence of SQC exhibited a slight decrease during this study period. The age rate ratio (ARR) of the incidence rate in men declined gradually, and the period effect changed more slowly for women than men. The cohort effect formed a bimodal curve. The annual percentage change results for women indicated that the ARR decreased from 1.652 (95% confidence interval (CI): 1.422, 1.9192) at 30 to 34 years to 0.559 (95% CI: 0.4988, 0.6265) at 75 to 79 years; the period effect decreased from 1.2204 (95% CI: 1.1148, 1.336) in 1995 to 1999 to 0.608 (95% CI: 0.5515, 0.6704) in 2015 to 2019, with a greater decline in the later period. The cohort effect was unimodal, with the SQC risk value peaking in the 1915 birth cohort and exhibiting a steady decline thereafter. The results of this study suggest that a decrease in the smoking rate may be the reason for the decline in the incidence of SQC, and we observed a similar trend between SQC and the smoking rate in men.

3 April 2023
Verified
Other
Open access
XZXiaotao Zhang
Xiaotao Zhang
KHKristi L. Hoffman
Kristi L. Hoffman
WPWei Peng
Wei Peng
KGKplola Y. Elhor Gbito
Kplola Y. Elhor Gbito
RJReji Joseph
Reji Joseph
CDCarrie R Daniel
Carrie R Daniel

3 April 2023
Verified
Other
Open access
XZXiaotao Zhang
Xiaotao Zhang
KHKristi L. Hoffman
Kristi L. Hoffman
WPWei Peng
Wei Peng
KGKplola Y. Elhor Gbito
Kplola Y. Elhor Gbito
RJReji Joseph
Reji Joseph
CDCarrie R Daniel
Carrie R Daniel

3 April 2023
Verified
Other
Open access
XZXiaotao Zhang
Xiaotao Zhang
KHKristi L. Hoffman
Kristi L. Hoffman
WPWei Peng
Wei Peng
KGKplola Y. Elhor Gbito
Kplola Y. Elhor Gbito
RJReji Joseph
Reji Joseph
CDCarrie R Daniel
Carrie R Daniel

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
MQMeina Quan
Meina Quan
XLXinyue Li
Xinyue Li
YWYiping Wei
Yiping Wei
WWWei Wang
Wei Wang
LXLingZhi Xu
LingZhi Xu
JJJianping Jia
Jianping Jia
Background: Transgenic mouse models are important tools for studying the pathogenesis of Alzheimer’s Disease (AD) and drug development. Commonly used models are constructed from early‐onset AD mutations in the Caucasian population, and are usually overexpression or knock‐in of multiple pathogenic gene mutations. However, they are not consistent with the genetic characteristics in real world where single gene mutation occurs most of the time. Furthermore, AD transgenic mouse models have been mostly depending on a few institutions/companies and limited by intellectual property protection.Method: We systematically summarized the research progress of a transgenic mouse model based on a single gene mutation (PS1V97L) found uniquely in Chinese familial AD, as well as the underling mechanisms such as Aβ oligomers (AβO) self‐replication (figure 1). We further compared them with other single‐transgene models, and summarized the preliminary findings of several drugs targeting AβO.Result: PS1V97L transgenic mice showed age‐related AD phenotypes such as Aβ accumulation, tau phosphorylation, neurofibrillary tangles, gliosis, synaptic degeneration and cognitive impairment (figure 2). The unique characteristics of this model is the aggregation of interneuronal AβO in cortex and hippocampus, but no plaques formed up to 24 months. Other mechanisms of PS1V97L model include oxidative stress, inflammation, abnormal energy metabolism, and alterations in AD‐related signaling pathways, such as PI3K/Akt and Nrf2/ARE pathways. Several drugs including sulforaphane, honokiol, tenuifolin, isoliquiritigenin, ginsenoside, butylphthalide and oxiracetam were found effective in PS1V97L mouse model as well as rat and cell models based on AβO mechanism.Conclusion: Although carrying only one mutation, PS1V97L transgenic mouse model can mimic almost all AD pathological phenotypes, and supports AβO pathogenic hypothesis. It provides important basic and translational tool for exploring the upstream mechanisms, risk factors, and multi‐target drug development in AD.

3 April 2023
Verified
Other
Open access
XZXiaotao Zhang
Xiaotao Zhang
KHKristi L. Hoffman
Kristi L. Hoffman
WPWei Peng
Wei Peng
KGKplola Y. Elhor Gbito
Kplola Y. Elhor Gbito
RJReji Joseph
Reji Joseph
CDCarrie R Daniel
Carrie R Daniel